International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

A Review: Formulation approaches for targeted drug delivery of drugs for Rheumatoid Arthritis

Author Affiliations

  • 1Department of Pharmaceutics, S.V.U.C.S, S.V. University, Tirupati, AP-517501, India
  • 2Department of Pharmaceutics, S.P.W. Polytechnic, Tirupati, AP-517501, India

Int. Res. J. Biological Sci., Volume 11, Issue (3), Pages 20-24, August,10 (2022)

Abstract

The aim of the present review article is focus on current status of Rheumatoid arthritis and to present various novel approaches for development of formulations and the techniques without inherent of side effects of antiarthritic drugs such NSAID. Rheumatoid arthritis is an auto immune disorder which followed by inflammation and disorder in function also causes depression. By using anti-inflammatory drugs and immunosuppressants together it can be treated. These drugs possess high fatal risk as they have not targeted to the receptor site and thus it shows severe adverse effects. Due to low bioavailability of these drugs, the drug candidates are potentially used in too high doses which causes adverse effects. In order to overcome these adverse effects, to increase the bioavailability and also to induce sustain release targeted drug delivery system may considered to be useful. By using the targeted drug delivery system, specificity of drugs increases, which increases bioavailability and the dose of administered drug get reduced.

References

  1. Merissa N Zeman, Peter JH Scott (2012)., Current imaging strategies in rheumatoid arthritis-Review Article., Am J Nucl Med Mol Imaging; 2(2), 174-181.
  2. Charles J. Malemud (2013)., Immunotherapies and Rheumatoid Arthritis-Introduction, Clinical & Cellular Immunology., 6, 2155-2162.
  3. Amandeep Kaur and S.L. Harikumar (2012)., Controlled Drug Delivery Approaches for Rheumatoid Arthritis., Journal of Applied Pharmaceutical Science; 02(08), 21-26.
  4. Iain B. McInnes and Georg Schett (2011)., Mechanisms of Disease the Pathogenesis of Rheumatoid Arthritis, review article., The new england journal of medicine, 23, 2205-2211.
  5. Gary S. (2013)., Firestein, Etiology and Pathogenesis of Rheumatoid Arthritis., part 9, 1035-1039.
  6. Kori A. Dewing, Stephen M. Barbara A. Slusher (2014)., Osteoarthritis and Rheumatoid Arthritis Pathophysiology., Diagnosis, and Treatment, special feature, 2(2), 35-42.
  7. R. Handa (2004)., Management of rheumatoid arthritis-review article., The National Medical Journal of India, (17), 133:143.
  8. Anne S. Vanniasinghe, Veronika Bender and Nicholas Manolios (2008)., The Potential of Liposomal Drug Delivery for the Treatment of Inflammatory Arthritis., Inflammatory Arthritis, 8, 182-190.
  9. Abolfazl Akbarzadeh, Rogaie Rezaei-Sadabady, Soodabeh Davaran (2013)., Liposome: classification, preparation, and Applications, nanoreview., Nanoscale Research Letters, 8, 102-108.
  10. Rajesh Mujoriya, Ramesh BabuBodla, Kishor Dhamande (2011)., Niosomal Drug Delivery System: The Magic Bullet., Journal of Applied Pharmaceutical Science, 01 (09), 20-28.
  11. Walve J.R*, Bakliwal S.R, Rane B.R, Pawar S.P. (2011)., Transferosomes: A Surrogated Carrier for Transdermal Drug Delivery System., International Journal of Applied Biology and Pharmaceutical Technology, 2(1), 204-211.
  12. Roopesh Sachan, Tarun Parashar, Soniya, Vishal Singh, Gaurav Singh and Satyanand Tyagi (2013)., Drug Carrier Transferosomes: A Novel Tool for Transdermal Drug Delivery System., International Journal of Research and Development in Pharmacy and Life Sciences, 2(2), 309-315.
  13. Tarun Parashar, Soniya, Roopesh Sachan, Vishal Singh, Gaurav Singh (2013)., Ethosomes: A Recent Vesicle of Transdermal Drug Delivery System., International Journal of Research and Development in Pharmacy and Life Sciences, 2, 285-292.
  14. Dilip Patel, Sandipan Dasgupta, Sanjay Dey (2012). Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation, Scientia Pharmaceutica, 80, 749-755., undefined, undefined
  15. Meghana S. Kamble, Krunal K. Vaidya and Ashok V (2012)., Solid Lipid Nanoparticles and Nanostructured Lipidcarriers – An Overview., International Journal of Pharmaceutical, Chemical and Biological Sciences, 2(4), 681-689.
  16. J. Ashok kumar and Nikhila pullakandam (2010)., Transdermal Drug Delivery System: An Overview., International Journal of Pharmaceutical Sciences Review and Research, 3(2), 49-54.
  17. Archana K. Gaikwad (2013)., Transdermal drug delivery system: Formulation aspects and evaluation, Comprehensive Journal of Pharmaceutical Sciences, 1(1), 1-6., undefined
  18. Nimish Shah, R. K. Mewada and Tejal Shah (2011)., Application of biodegradable Polymers in Controlled drug Delivery., International Conference on Current Trends in Technology, 08, 52-60.
  19. Nagavarma B V N, Hemant K. S. Yadav, Ayaza, Vasudha L.S, (2012)., Different Techniques For Preparation of Polymeric Nanoparticles- A Review, Asian Journal of Pharmaceutical and Clinical Research, 5, 16-24., undefined